Results 201 to 210 of about 48,106 (232)

An atypical initial revelation of CACH-vanishing white matter syndrome miming herpetic encephalitis in a 6-year-old child: Case report and brief review. [PDF]

open access: yesRadiol Case Rep
Mohammed C   +9 more
europepmc   +1 more source

Therapeutic landscape of ovarian cancer: recent advances and emerging therapies. [PDF]

open access: yesBiomark Res
Wang L   +7 more
europepmc   +1 more source

Advances in the Diagnosis of Reproductive Disorders in Female Camelids. [PDF]

open access: yesAnimals (Basel)
Sghiri A   +4 more
europepmc   +1 more source

Tumores limítrofes del ovario

open access: yes, 2005
J. Grases, Pedro   +1 more
openaire   +1 more source

Cáncer de ovario

Medicine - Programa de Formación Médica Continuada Acreditado, 2013
Resumen Introduccion El cancer de ovario se asocia a una elevada mortalidad, debido a que en la mayoria de las pacientes se diagnostica en estadios avanzados. Diagnostico/tratamiento La estadificacion se establece tras la realizacion de una cirugia reglada, y supone el principal factor pronostico de esta enfermedad.
A. Redondo Sánchez   +3 more
openaire   +2 more sources

Classificação de Carcinoma Endometrioide de Ovário por Transformação de Esquema de Cor e Radiomics em Imagens Histopatológicas

Anais do XXV Simpósio Brasileiro de Computação Aplicada à Saúde (SBCAS 2025)
Carcinoma endometrioide de ovário (CEO) é um subtipo do câncer de ovário com diagnóstico desafiador em imagens histopatológicas. Redes neurais convolucionais (CNNs) são amplamente utilizadas nessa tarefa, mas exigem grandes volumes de dados e alta carga ...
Breno A. Tamanini   +7 more
semanticscholar   +1 more source

Phase II OVARIO study of niraparib + bevacizumab therapy in advanced ovarian cancer following front-line platinum-based chemotherapy with bevacizumab

Gynecologic Oncology, 2020
Objectives: Niraparib improves progression-free survival (PFS) in newly diagnosed, recurrent, and heavily pretreated ovarian cancer (OC) in patients (pts) after platinum-based chemotherapy in all biomarker-defined subgroups.
M. Hardesty   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy